Eu Ivdd Eu Ivd General On The Market 🇨🇳 China

ICervsure

Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0

Basic Information

Primary DI
D-AD02-96CE79
Basic UDI-DI Code
B-AD02-96CE79
Reference
AD02-96CE
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market

Additional Description

This product is intended for the in vitro qualitative detection of methylated SOX1 and PAX1 genes in cervical exfoliated cells of individuals who are tested positive for HPV, or diagnosed, through clinical cytology tests, with the results of ASC-US (atypical squamous cells of ambiguous significance), ASC-H (atypical cells of high-grade squamous intraepithelial lesions that could not be excluded), LSIL (low-grade squamous intraepithelial lesions) and HSIL (high-grade squamous intraepithelial lesions)

CND Nomenclature Codes

Code Description
W01060299 TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHER

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all